• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of the mechanism of defective autologous mixed lymphocyte reaction in cancer patients

Research Project

Project/Area Number 03670596
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionWakayama Medical College

Principal Investigator

YAMAUE Hiroki  Wakayama Medical College, Associate Professor, 医学部, 講師 (20191190)

Co-Investigator(Kenkyū-buntansha) NAKAI Takehiro  Wakayama Medical College, Instructor, 医学部, 助手 (70227726)
IWAHASHI Makoto  Wakayama Medical College, Instructor, 医学部, 助手 (70244738)
Project Period (FY) 1991 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1993: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1992: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1991: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsAutologous mixed lymphocyte reaction / Gastric carcinoma / Autoreactive T cell / HLA-DR antigen / AMLR-killer / Autologous tumor-killing activity / Immune Surveillance / AMLR-killer / CD4、CD8 / ヘルパーT細胞 / Interleukin-2 / Interleukin-2 receptor / 脾臓 / 免疫監視機構 / HLAーDR抗原
Research Abstract

The AMLR in cancer patients was suppressed compared with that in controls, and its suppression was observed even in early-stage patients. The expression of HLA-DR antigen on non-T cells was suppressed in cancer patients. Neither CD4+ nor CD8+ cells sorted from T cells of cancer patients had enough response to auto-non-T cells. The proliferative response of autoreactive T cell clone from the spleen of a cancer patient was also suppressed. It is suggested that these disturbances cause the suppression of the AMLR in cancer patients.
The non-specific or autologous tumor-specific cytotoxic activity was generated in the AMLR.This cytotoxic activity was impaired in cancer patients, and related with AMLR activity. The major population of AMLR-killer cells recognizing autologous tumor cells was CD4+. Autoreactive CD4+ T cell clones had cytotoxic activity against auto-PHA blasts, but not allo-PHA blasts. It is suggested that autoreactive T cell clones have autotumor-killing activity.
Thus, the mechanism of self-recognition represented by AMLR might play a very important role in immunological surveillance in cancer patients, which was proved by clinical course of postoperative patients.

Report

(4 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • 1991 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Iwahashi M.et al: "Defective autologous mixed lymphocyte reaction(AMLR)and killer activity generated in the AMLR in cancer patients." International Journal of Cancer. 51. 67-71 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yamaue H.et al: "Chemosensitivity testing with highly purified fresh human tumor cells using the MTT colorimetric assay" European Journal of Cancer. 27. 1258-1263 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yamaue H.et al: "Enhancement of tumor cell susceptibility to lymphckine-activated killer cells by treatment with the streptococcal preparation OK432." Biotherapy. 5. 83-93 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yamaue H.et al: "Clinical and immunolegical evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer." Journal of Surgical Oncology. 49. 10-15 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yamaue H.et al: "Chemosensitivity testing of fresh human gastric cancer with highly purified tumor cells using the MTT assay." British Journal of Cancer. 60. 794-799 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tsunoda T.et al: "The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor." Biotherapy. 4. 9-15 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Makoto Iwahashi et al.: "Defective autologous mixed lymphocyte reaction(AMLR)and killer activity generated in the AMLR in cancer patient" International Journal of Cancer. 51. 1-5 (1992)

    • Related Report
      1993 Annual Research Report
  • [Publications] Makoto Iwahashi et al.: "An autoreactive Tcell clone generated in the autologous mixed lymphocyte reaction in a patient with gastric carcinoma" Journal of Clinical and Laboratory Immunology. (submitted). (1994)

    • Related Report
      1993 Annual Research Report
  • [Publications] Makoto Iwahashi et al: "Non-Tcell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma" Caneer Immunology Immunotherapy. (Submitted).

    • Related Report
      1993 Annual Research Report
  • [Publications] Hiroki Yamaue et al: "Chemosensitivity testing with highly purified fresh human tumor cells with MTT colorimetric assay" European Journal of Cancer. 27. 1258-1263 (1991)

    • Related Report
      1993 Annual Research Report
  • [Publications] Hiroki Yamaue et al.: "Chemosensitivity testing of fresh human gastric cancer with highly purified fumor cells" British Journal of Cancer. 66. 794-799 (1992)

    • Related Report
      1993 Annual Research Report
  • [Publications] Makoto Iwahashi et al.: "Association between autologous mixed lymphocyte reaction and postoperative prognosis in patients with gastric carinoma" J Nat Cancer Inst. (Submitted.).

    • Related Report
      1993 Annual Research Report
  • [Publications] Makoto Iwahashi: "Detective autologous mixed lymphocyte rzaction(AMLR)and Killer activity generated in the AMLR in cancer Prtient" Internatioal Journal of Cancer. 51. 1-5 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Hiroki Yamaue: "Chemosensitivity testing of human gastric cancer with highly purified tumor cells using the MTT assay" British Journal of Cancer. 66. 794-799 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Hiroki Yamaue: "Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal prepatation ok432" Biotherapy. 5. 83-93 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Hiroki Yamaue: "Cisplation treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells." J.Uin,Lab.Immunol.35. 165-170 (1991)

    • Related Report
      1992 Annual Research Report
  • [Publications] Masaji Tani: "In vitro generation of actiVatcd Natural killer cells and cytotoxic macrophages with lentiman" European Journal of Cltnical Pharmacology. 42. 623-628 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Makoto Iwahashi: "An autorenctive T cell clone generated inthe autologous mixed lymphocyte reaction in a patient with Jastuc cancer" Cancer Research.

    • Related Report
      1992 Annual Research Report
  • [Publications] Makoto Iwahashi et al.: "Detective autologous mixed lymphocyte reaction(AMLR)and killer activity generated in the AMLR in cancer patients." International Journal of Cancer. 51. 1-5 (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Hiroki Yamaue et al.: "Chemosensitivity testing with highly purified fresh tuman tuman cells with the MTT colorimetric assay" European Journal of Cancer. 27. 1258-1263 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Hiroki Yamaue et al.: "Clinical and immurological ovaluation of intraoperative radiation therapy for patients with unqesectable panoreatic cancer" Journal of Surgical Oncology. 49. 10-15 (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Hiroki Yamaue et al: "Cisplatin treatment renders tumor cells more susceptible to attack by lymphokineーactivated killer cells." European Journal of Cancer. (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Takuya Tsunoda et al.: "In vitro augmentation of the cytotoxic activity of periphcral blood mononuclear cells and tumorーinfiltwting lymphocytes by famotidine in cancer patients" International Journal of Immunopharmacology. 14. 75-81 (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Takuya Tsunoda et al.: "The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumorーinfiltrating lymphocytes from patients with malignant tumor" Biotherapy. 4. 9-15 (1992)

    • Related Report
      1991 Annual Research Report

URL: 

Published: 1991-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi